We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
-10.91%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$496M
AUM Growth
-$54.3M
Cap. Flow
+$14.3M
Cap. Flow %
2.89%
Top 10 Hldgs %
37.7%
Holding
138
New
9
Increased
41
Reduced
59
Closed
9

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$9.45M
2
GVA icon
Granite Construction
GVA
+$6.47M
3
BMY icon
Bristol-Myers Squibb
BMY
+$3.74M
4
GSK icon
GSK
GSK
+$3.67M
5
XRAY icon
Dentsply Sirona
XRAY
+$3.06M

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$11.5M
2
IBM icon
IBM
IBM
+$5.1M
3
MRK icon
Merck
MRK
+$3.95M
4
EXC icon
Exelon
EXC
+$3.95M
5
NEE icon
NextEra Energy
NEE
+$3.71M

Sector Composition

Rank Sector Weight
1 Healthcare 26.2%
2 Industrials 23.34%
3 Technology 17.78%
4 Utilities 8.88%
5 Miscellaneous 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$33.7M 6.79%
563,620
+140,179
+33% +$9.45M
XOM icon
2
ExxonMobil
XOM
$644B
$28.7M 5.78%
420,529
+14,510
+4% +$1.14M
GLW icon
3
Corning
GLW
$128B
$19.8M 4%
656,337
-11,253
-2% -$359K
PFE icon
4
Pfizer
PFE
$159B
$19.4M 3.92%
468,684
-4,399
-0.9% -$183K
GVA icon
5
Granite Construction
GVA
$5.44B
$16.5M 3.32%
408,634
+141,625
+53% +$6.47M
MRK icon
6
Merck
MRK
$366B
$15.1M 3.04%
206,468
-56,017
-21% -$3.95M
INTC icon
7
Intel
INTC
$473B
$14.8M 2.98%
315,288
-2,990
-0.9% -$140K
NVS icon
8
Novartis
NVS
$292B
$13.9M 2.8%
180,597
-762
-0.4% -$59.3K
ABT icon
9
Abbott
ABT
$195B
$12.7M 2.56%
175,517
-3,697
-2% -$260K
JNJ icon
10
Johnson & Johnson
JNJ
$646B
$12.4M 2.51%
96,371
-4,226
-4% -$589K
BMY icon
11
Bristol-Myers Squibb
BMY
$136B
$12.3M 2.48%
236,799
+69,659
+42% +$3.74M
OGE icon
12
OGE Energy
OGE
$9.45B
$11.6M 2.33%
295,293
-2,340
-0.8% -$89.8K
LNN icon
13
Lindsay Corp
LNN
$1.16B
$11.2M 2.25%
115,920
-1,078
-0.9% -$105K
EEMV icon
14
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.65B
$10.9M 2.2%
194,981
+54,400
+39% +$3.05M
MSFT icon
15
Microsoft
MSFT
$3.81T
$9.94M 2.01%
97,879
-2,583
-3% -$277K
BCE icon
16
BCE
BCE
$21.9B
$9.45M 1.91%
239,145
+300
+0.1% +$12.3K
CIEN icon
17
Ciena
CIEN
$53.6B
$9.12M 1.84%
268,900
-6,100
-2% -$193K
EVRG icon
18
Evergy
EVRG
$18.6B
$9.1M 1.83%
160,208
-3,527
-2% -$204K
FLS icon
19
Flowserve
FLS
$10.2B
$8.99M 1.81%
236,435
+51,000
+28% +$2.39M
TT icon
20
Trane Technologies
TT
$98.8B
$8.47M 1.71%
92,833
-2,320
-2% -$228K
MDU icon
21
MDU Resources
MDU
$4.16B
$8.44M 1.7%
931,298
+8,916
+1% +$87K
XRAY icon
22
Dentsply Sirona
XRAY
$2.22B
$8.39M 1.69%
225,500
+84,000
+59% +$3.06M
LGTY
23
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$8.31M 1.68%
795,121
+218,416
+38% +$2.41M
GSK icon
24
GSK
GSK
$102B
$7.67M 1.55%
160,560
+74,532
+87% +$3.67M
WTS icon
25
Watts Water Technologies
WTS
$12.2B
$7.27M 1.47%
112,608
+4,750
+4% +$341K

Similar funds

John G. Ullman & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, John G. Ullman & Associates held 138 positions worth $496M, down 9.9% from $550M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

John G. Ullman & Associates's Q4 2018 filing shows 9 new, 41 increased, 59 reduced and 9 closed positions. Its largest new stake was Astec Industries: 74,600 shares worth $2.25M. The largest sale was SLB Ltd, an estimated $11.5M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q4 2018 buy was Astec Industries: 74,600 shares worth $2.25M.
  • John G. Ullman & Associates added most to Emerson Electric in Q4 2018, an estimated $9.45M increase.
  • John G. Ullman & Associates's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $11.5M.
  • John G. Ullman & Associates fully exited Swiss Helvetia Fund in Q4 2018, selling an estimated $2.51M.
  • John G. Ullman & Associates's ten largest holdings make up 38% of its $496M portfolio in Q4 2018.
  • John G. Ullman & Associates opened 9 new positions and closed 9 in Q4 2018.
  • John G. Ullman & Associates's portfolio value fell 9.9% quarter-over-quarter to $496M.

Based on John G. Ullman & Associates's 13F filing for Q4 2018, filed 29 Jan 2019.